97061 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interferons [IFN]
CLEC9A BINDING AGENTS
#2HUMAN A INTERFERON RECEPTOR BINDING-RELATED SITE MUTANT AND USE THEREOF
#3CD8 BINDING AGENTS
#4SWITCH RECEPTORS AND MODIFIED IMMUNE CELLS
#5INDUCIBLE CHIMERIC CYTOKINE RECEPTORS
#6TUNABLE CYTOKINE RECEPTOR SIGNALING DOMAINS
#7Compositions and Methods for Treating Cancer and Viral Infections
#8Combination Therapy with Gold Controlled Transgenes
#9COMPOSITIONS AND METHODS FOR TREATMENT OF SJÖGREN'S SYNDROME AND/OR SYSTEMIC LUPUS ERYTHEMATOSUS
#10IMPROVED PRIMARY HUMAN NK CELL EXPANSION AND FUNCTION BY CHIMERIC CYTOKINE RECEPTOR
#11ENGINEERING B CELLS TO EXPRESS CHIMERIC ANTIGEN RECEPTORS (CARS) AND USES THEREOF FOR T CELL INDEPENDENT ACTIVATION
#12INTERFERON RECEPTOR ANTAGONISTS AND USES THEREOF
#13SELF-POLARIZING IMMUNE CELLS
#14ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF
#15COMPOSITIONS AND METHODS COMPRISING PROTEASE-ACTIVATED THERAPEUTIC AGENTS
#16Adenovirus armed with bispecific T cell activator
#17ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF
#18INTERFERON RECEPTOR AGONISTS AND USES THEREOF
#19Interferon Prodrugs and Methods of Making and Using the Same
#20INTERFERON RECEPTOR AGONISTS AND USES THEREOF
#21NK CELLS OR T CELLS EXPRESSING CHIMERIC HEMATOPOIETIC GROWTH FACTOR RECEPTORS AND METHODS OF USE
#22ARTIFICIAL ALPHAVIRUS-DERIVED RNA REPLICON EXPRESSION SYSTEMS
#23HETERODIMERIC PROTEINS AND USES THEREOF
#24A MIXTURE OF MRNA TO ENHANCE THE POTENCY OF DENDRITIC CELLS
#25ENGINEERED T CELLS
#26CLEC9A BINDING AGENTS
#27Artificial alphavirus-derived RNA replicon expression systems
#28DIMER IMMUNOADHESIN, PHARMACEUTICAL COMPOSTION AND USE THEREOF
#29Combination therapy with gold controlled transgenes
#30CD20 BINDING SINGLE DOMAIN ANTIBODIES
#31CD8 BINDING AGENTS
#32TYPE 1 INTERFERON NEUTRALIZING FC-FUSION PROTEIN AND USE THEREOF
#33QTY FC fusion water soluble receptor proteins
#34Materials and methods for treatment with oncolytic viruses and modified CAR T cells
#35Heterodimeric proteins and uses thereof
#36Polynucleotides heterodimers of soluble interferon receptors and uses thereof
#37BISPECIFIC SIGNALING AGENTS AND USES THEREOF
#38ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF
#39INHIBITION OF INNATE IMMUNE RESPONSE
#40Combination Therapy with Gold Controlled Transgenes
#41Adenovirus armed with bispecific T cell activator
#42INTERFERON PRODRUG FOR THE TREATMENT OF CANCER
#43Heterodimeric proteins and uses thereof
#44Bispecific signaling agents and uses thereof
#45Clec9A binding agents
#46TISSUE-BASED BIOLOGICS FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISORDERS
#47Inducible chimeric cytokine receptors
#48Heterodimers of soluble interferon receptors and uses thereof
#49CD20 binding single domain antibodies
#50CD8 binding agents
#51Fusion proteins for promoting an immune response, nucleic acids encoding same, and methods of making and use thereof
#52Inhibition of innate immune response
#53Methods for increasing levels of interferon activity with an interferon lambda 3 polypeptide
#54Method for increasing interferon activity in an individual
#55STING crystals and modulators
#56Method of improving the pharmacokinetic profile of a therapeutic polypeptide and the use thereof
#57Methods for treating or ameliorating multiple sclerosis
#58Fusion proteins for promoting an immune response, nucleic acids encoding same, and methods of making and use thereof
#59IFNγR2 compositions and methods of inhibiting neuronal cell death
#60Inhibition of innate immune response
#61Peptide-based inhibitor of interleukin-10 or interferon-gamma signaling
#62Nucleic acids encoding TNFγ
#63Compositions and methods for treatment of cancer
#64Interferon-lambda 1 polypeptides
#65MODIFIED LINKERS
#66IFN-ALPHA/BETA-INDEPENDENT MECHANISM OF ANTIVIRAL PROTECTION THROUGH A NOVEL LIGAND-RECEPTOR PAIR: IFN- LIGANDS ENGAGE A NOVEL RECEPTOR IFN-RN (CRF2-12) AND IL-10R2 (CRF2-4) FOR SIGNALING ANDINDUCTION OF BIOLOGICAL ACTIVITIES
#67Nucleic acid encoding TNFx protein
#68Compositions and Methods for Treatment of Neoplastic Disease
#69STRATEGY FOR HOMO- OR HETERO-DIMERIZATION OF VARIOUS PROTEINS IN SOLUTION AND IN CELL
#70Interferon gamma receptor beta chain compositions and methods of inhibiting apoptosis
#71INTERFERON FUSION PROTEINS
#72INTERFERON LAMBDA FUSION POLYPEPTIDES
#73IFNAR2 MUTANTS, THEIR PRODUCTION AND USE
#74Mammalian genes; related reagents and methods
#75Interleukin-17 receptor homologue
#76METHOD FOR THE PRODUCTION OF HIGH-LEVEL SOLUBLE HUMAN RECOMBINANT INTERFERON ALPHA IN E. COLI AND VECTORS USEFUL FOR SUCH A PRODUCTION
#77IFN-λ polypeptides and compositions
#78Genetic Polymorphisms As Predictive Diagnostics For Adverse Drug Reactions (ADR) And Drug Efficacy
#79METHOD FOR RECOMBINANT PRODUCTION IN CHO CELLS
#80Mammalian genes; related reagents and methods
#81Compositions and methods for treatment of neoplastic disease
#82Monoclonal Antibodies Against The Interferon Receptor, With Neutralizing Activity Against Type I Interferon
#83Anth1 chimeric antagonist
#84Leader sequences for use in production of proteins
#85Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
#86Treatment of Inflammatory Bowel Disease with IFN-Gamma Inhibitors
#87INTERLEUKIN-17 RECEPTOR HOMOLOGUE
#88Interleukin-17 receptor homologue
#89Therapeutic peptides
#90INTERLEUKIN-17 RECEPTOR HOMOLOGUE
#91INTERLEUKIN-17 RECEPTOR HOMOLOGUE
#92Polynucleotides encoding interleukin-17 receptor homologue
#93INTERLEUKIN-17 RECEPTOR HOMOLOGUE
#94Antibodies that bind interleukin-17 receptor homologue
#95Vectors encoding interleukin-17 receptor homologue
#96TREATMENT OF INFLAMMATORY BOWEL DISEASE WITH IFN-GAMMA INHIBITORS
#97Interferon-α/β binding fusion proteins and therapeutic uses thereof
#98Genetic polymorphisms as predictive diagnostics for adverse drug reactions (adr) and drug efficacy
#99Chimeric antagonist anth1
#100Methods of treating ocular inflammation and allergy
#101Antibodies binding the TNF related protein, TNF-Y
#102IFNAR2 mutants, their production and use
#103Compositions and methods for treatment of neoplastic disease